Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 89 for pediatric

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Prevalence of Hypervigilant Eating Habits in Pediatric Patients With Gastrointestinal Symptoms

    Rochester, MN

  2. A Study to Evaluate the Spectrum of Healthy Pediatric Inflammatory Responses to Vaccinations

    Rochester, MN

  3. A Study Of Upper Extremity And Functional Outcomes In Pediatric Brachial Plexus Injury

    Rochester, MN

  4. Medical Interpreters Work Experiences With Pediatric Physical Therapists, Patients, and Families During Outpatient Physical Therapy Sessions

    Rochester, MN

  5. A Study Of Hyperselective Neurectomies For Elbow Flexion Spasticity In A Pediatric Population

    Rochester, MN

  6. Clinical Outcomes Of Medications Post Anti-TNF: Researching Effectiveness In Pediatric IBD

    Rochester, MN

  7. Wide Local Excision For Pediatric Malignant Sarcomas And Learning, Behavioral, And Socioeconomic Outcomes

    Rochester, MN

  8. Predicting Disease Progression in Pediatric Patients With Autosomal Dominant Polycystic Kidney Disease Using Urinary Crystal Burden as a Biomarker

    Rochester, MN

  9. A Study to Evaluate Patient Reported Outcome Measures in Children with Eye Conditions

    Rochester, MN

  10. Diagnosing Craniosynostosis MR with Facial Recognition Software

    Rochester, MN

.

Mayo Clinic Footer